Crossref
S2-1 製薬企業におけるRWD/RWE活用の現状及び課題
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · 2025 · 30 (Supplement) · S80-S80
DOI: 10.3820/jjpe.30.s80 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 2025. Verfasst von 事成 青木.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
青木, 事. (2025). S2-1 製薬企業におけるRWD/RWE活用の現状及び課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 30(Supplement), S80-S80. https://doi.org/10.3820/jjpe.30.s80
Vancouver
青木 事. S2-1 製薬企業におけるRWD/RWE活用の現状及び課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2025;30(Supplement):S80-S80. doi:10.3820/jjpe.30.s80
BibTeX
@article{2025,
author = {青木, 事成},
title = {S2-1 製薬企業におけるRWD/RWE活用の現状及び課題},
journal = {Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku},
year = {2025},
volume = {30},
number = {Supplement},
pages = {S80--S80},
doi = {10.3820/jjpe.30.s80}
}
EUVIMED